Fulgent Genetics (FLGT) Stock Statistics & Valuation Metrics

Fulgent Genetics has a market cap or net worth of $466.90M. The enterprise value is $417.18M.

Fulgent Genetics has 31,230,633 shares outstanding. The number of shares has decreased by -2.65% in one year.

Fulgent Genetics’s return on equity (ROE) is -0.05 and return on invested capital (ROIC) is -7.10%.

The current PE Ratio of Fulgent Genetics is ―. Fulgent Genetics’s PEG ratio is -0.34.

In the last 12 months, Fulgent Genetics had revenue of 322.67M and earned -60.51M in profits. Earnings per share was -1.97.

In the last 12 months, operating cash flow was -101.64M and capital expenditures -22.57M, giving a free cash flow of -124.21M billion.

Fulgent Genetics pays an annual dividend of ―, resulting in a dividend yield of ―

Fulgent Genetics upcoming earnings date is May 1, 2026, After Close (Confirmed).

Fulgent Genetics as a current ratio of 6.48, with Debt / Equity ratio of 0.04%

In the past 12 months, Fulgent Genetics has paid -8.39M in taxes.

Fulgent Genetics EV to EBITDA ratio is -16.56, with an EV/FCF ratio of -6.11.

Fulgent Genetics has $336.08M in cash and marketable securities with $476.00K in debt, giving a net cash position of $335.60M billion.

Gross margin is 40.56%, with operating margin of -28.23%, and net profit margin of -18.75%.

The average price target for Fulgent Genetics is $22.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy